JPWO2020219748A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020219748A5 JPWO2020219748A5 JP2021562914A JP2021562914A JPWO2020219748A5 JP WO2020219748 A5 JPWO2020219748 A5 JP WO2020219748A5 JP 2021562914 A JP2021562914 A JP 2021562914A JP 2021562914 A JP2021562914 A JP 2021562914A JP WO2020219748 A5 JPWO2020219748 A5 JP WO2020219748A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- linker
- binding
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838255P | 2019-04-24 | 2019-04-24 | |
| US62/838,255 | 2019-04-24 | ||
| US201962841739P | 2019-05-01 | 2019-05-01 | |
| US62/841,739 | 2019-05-01 | ||
| PCT/US2020/029618 WO2020219748A2 (en) | 2019-04-24 | 2020-04-23 | Anti-cd117 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529727A JP2022529727A (ja) | 2022-06-23 |
| JPWO2020219748A5 true JPWO2020219748A5 (https=) | 2022-09-20 |
| JP2022529727A5 JP2022529727A5 (https=) | 2022-09-20 |
Family
ID=72941301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562914A Withdrawn JP2022529727A (ja) | 2019-04-24 | 2020-04-23 | Anti-cd117 とその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220177578A1 (https=) |
| EP (1) | EP3959243A4 (https=) |
| JP (1) | JP2022529727A (https=) |
| WO (1) | WO2020219748A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121555430A (zh) | 2018-05-11 | 2026-02-24 | 比姆医疗股份有限公司 | 使用可编程碱基编辑器系统取代病原性氨基酸的方法 |
| WO2022187050A1 (en) * | 2021-03-01 | 2022-09-09 | BioLegend, Inc. | Anti-cd117 agents and compositions and methods for making and using the same |
| WO2023111311A1 (en) * | 2021-12-16 | 2023-06-22 | Universität Basel | Discernible cell surface protein variants of cd117 for use in cell therapy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9540443B2 (en) * | 2011-01-26 | 2017-01-10 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies |
| AR086044A1 (es) * | 2011-05-12 | 2013-11-13 | Imclone Llc | Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos |
| NZ710929A (en) * | 2013-03-15 | 2018-02-23 | Novartis Ag | Antibody drug conjugates |
| WO2015050959A1 (en) * | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| WO2015067667A1 (en) * | 2013-11-05 | 2015-05-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Human neutralizing anti-kit antibodies and uses thereof |
| US10786578B2 (en) * | 2014-08-05 | 2020-09-29 | Novartis Ag | CKIT antibody drug conjugates |
| BR112018076306A2 (pt) * | 2016-06-17 | 2019-03-26 | Magenta Therapeutics, Inc. | composições e métodos para a supressão de células cd117+ |
| CA3079215A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| WO2019084067A1 (en) * | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODIES AND METHODS OF USE |
| WO2019234694A2 (en) * | 2018-06-07 | 2019-12-12 | Magenta Therapeutics, Inc. | Therapeutic methods using antibody drug conjugates (adcs) |
-
2020
- 2020-04-23 JP JP2021562914A patent/JP2022529727A/ja not_active Withdrawn
- 2020-04-23 EP EP20794877.9A patent/EP3959243A4/en not_active Withdrawn
- 2020-04-23 WO PCT/US2020/029618 patent/WO2020219748A2/en not_active Ceased
-
2021
- 2021-10-22 US US17/508,766 patent/US20220177578A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7641452B2 (ja) | Cd117+細胞を減少させるための組成物及び方法 | |
| US11572411B2 (en) | Anti-CD117 antibodies and conjugates | |
| US12291576B2 (en) | Anti-CD45 antibodies and conjugates thereof | |
| JP7716399B2 (ja) | 抗-cd45抗体及びそのコンジュゲート | |
| US20220177575A1 (en) | Anti-cd117 antibodies and uses thereof | |
| JP2021500375A5 (https=) | ||
| CN119857155A (zh) | 用于耗尽cd5+细胞的组合物和方法 | |
| JP2022529726A5 (https=) | ||
| JPWO2020092654A5 (https=) | ||
| US20220177578A1 (en) | Anti-cd117 antibodies and uses thereof | |
| JP2022529727A5 (https=) | ||
| JPWO2020219770A5 (https=) | ||
| CA3168039A1 (en) | Compositions and methods for allogeneic transplantation | |
| JPWO2021087368A5 (https=) | ||
| JPWO2020219748A5 (https=) |